Type 2 diabetes
Conditions
Interventions
D-psicose is orally administered 15 g / day
Sponsors
kagawa university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Type 2 diabetes patients (HbA1c 6.5% or more) who can not obtain sufficient effect by any of the following treatments 1) Diet therapy or exercise therapy only 2) Pharmacotherapy in addition to diet therapy and exercise therapy
Exclusion criteria
Exclusion criteria: 1) Patients falling under D-psicose administration contraindications 2) Patients participating in other clinical trials 3) A pregnant woman, a maternity woman, a lactating woman or a woman having a possibility of pregnancy 4) Patients who have poor glycemic control with HbA1c> 8% 5) Patients who have severe renal dysfunction (serum creatinine value> 1.5 mg / dl) 6) Patients with other serious complications 7) Other patients judged inappropriate for judgment by other doctor's judgment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The change amount of HbA1c value at the 12th week after administration from the start of administration | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in fasting blood glucose level or 2-hour postprandial blood glucose level and other blood test items | — |
Countries
Japan
Contacts
Public Contactkoji murao
kagawa university Department of Endocrinology and Metabolism, Faculty of Medicine
Outcome results
None listed